Substance abuse and depression

Substance Abuse in the Mentally and Physically Disabled

Volumn , Issue , 2001, Pages 33-58

  Lehmann, Lauren P ^a   Hubbard, John R ^b   Martin, Peter R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748282651     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (192)

1. HE Ross, FB Glaser, T Germanson. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 45: 1023-1031, 1988.
2. NS Miller, D Klamen, NG Hoffmann, JA Flaherty. Prevalence of depression and alcohol and other drug dependence in addictions treatment populations. J Psychoact Drugs 28: 111-124, 1996.
3. DA Charney, AM Paraherakis, JC Negrete, KJ Gill. The impact of depression on the outcome of addictions treatment. J Subst Abuse Treat 15: 123-30, 1998.
4. ID Montoya, D Svikis, SC Marcus, A Suarez, T Tanielian, HA Pincus. Psychiatric care of patients with depression and comorbid substance use disorders. J Clin Psychiatry 61: 696-705, 2000.
5. BF Grant. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse 7: 481-497, 1995.
6. MQ Wang, CB Collins, RJ DiClemente, G Wingood, CL Kohler. Multiple drug use and depression: gender differences among African-Americans in a high-risk community. J Alcohol Drug Education 43: 87-96, 1997.
7. B Donohue, R Acierno, E Kogan. Relationship of depression with measures of social functioning adult drug abusers. Addict Behav 21: 211-216, 1996.
8. MQ Wang, CB Collins, RJ DiClemente, G Wingood, CL Kohler. Depressive symptoms as correlates of polydrug use for blacks in a high-risk community. South Med J 90: 1123-1128, 1997.
9. J Westermeyer, S Kopka, S Nugent. Course and severity of substance abuse among patients with comorbid major depression. Am J Addictions 6: 284-292, 1997.
10. RE Meyer. How to understand the relationship between psychopathology and addictive disorders: another example of the chick and the egg. In: Psychopathology and Addictive Disorders. RE Meyer, ed. New York: Guilford Press, 1986.
11. JD Swendsen, KR Merikangas. The comorbidity of depression and substance use disorders. Clin Psychol Rev 20: 173-189, 2000.
12. A Markou, TR Kosten, GF Koob. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18(3): 135-174, 1998.
13. SC Dilsaver. The pathophysiologies of substance abuse and affective disorders: an integrative model?. J Clin Psychopharmacol 7: 1-10, 1987.
14. RM Anthenelli, MA Schuckit. Affective and anxiety disorders. In: Principles of Addiction Medicine. NS Miller, ed. Chevy Chase, MD: American Society of Addiction Medicine, 1994.
15. JR Cornelius, IM Salloum, NL Day, ME These, JJ Mann. Patterns of suicidality and alcohol use in alcoholics with major depression. Alcohol Clin Exp Res 20: 1451-1455, 1996.
16. MT Lynskey. The comorbidity of alcohol dependence and affective disorders: treatment implications. Drug Alcohol Depend 52: 201-209, 1998.
17. BF Grant, TC Harford. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 39: 197-206, 1995.
18. MM Weissman, JK Myers. Clinical depression in alcoholism. Am J Psychiatry 137: 372-373, 1980.
19. A Roy. Neuroticism and depression in alcoholics. J Affect Disord 52: 243-245, 1999.
20. A Roy. Aetiology of secondary depression in male alcoholics. Br J Psychiatry 169: 753-757, 1996.
21. DA Dawson, BF Grant. Family history of alcoholism and gender: their combined effects on DSM-IV alcohol dependence and major depression. J Stud Alcohol 59: 97-106, 1998.
22. W Maier, K Merikangas. Co-occurrence and contransmission of affective disorders and alcoholism in families. Br J Psychiatry June (suppl): 93-100, 1996.
23. EZ Hanna, BF Grant. Gender differences in DSM-IV alcohol use disorders and major depression as distributed in the general population: clinical implications. Compr Psychiatry 38: 202-212, 1997.
24. SJ Waller, JS Lyons, MF Costantini-Ferrando. Impact of comorbid affective and alcohol use disorders on suicidal ideation and attempts. J Clin Psychol 55: 585-95, 1999.
25. BF Grant, DS Hasin. Suicidal ideation among the United States drinking population: results from the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol 60: 422-429, 1999.
26. A Porsteinsson, PR Duberstein, Y Conwell, C Cox, N Forbes, ED Caine. Suicide and alcoholism: distinguishing alcoholic patients with and without cormorbid drug abuse. Am J Addict 6: 304-310, 1997.
27. A Roy, D Lamparski, J DeJong, V Moore, M Linnoila. Characteristics of alcoholics who attempt suicide. Am J Psychiatry 147: 761-765, 1990.
28. GE Murphy, RD Wetzel, E Robins, L McEvoy. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry 49: 459-463, 1992.
29. K Schaefer, N Butters, T Smith, M Irwin, S Brown, P Hanger, I Grant, M Schuckit. Cognitive performance of alcoholics: a longitudinal evaluation of the role of drinking history, depression, liver function, nutrition and family history. Alcohol Clin Exp Res 15: 653-660, 1991.
30. S Glenn, A Errico, O Parsons, A King, S Nixon. The role of antisocial, affective and childhood behavioral characteristics in alcoholics’ neurological performance. Alcohol Clin Exp Res 17: 162-169, 1993.
31. PN Tariot, H Weingartner. A psychobiological analysis of cognitive failures. Arch Gen Psychiatry 43: 1183-1188, 1986.
32. RMA Hirschfeld, T Kosier, MB Keller, PW Lavori, J Endicott. The influence of alcoholism on the course of depression. J Affect Disord 16: 151-158, 1989.
33. DS Hasin, WY Tsai, J Endicott, TI Mueller, W Coryell, M Keller. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord 41: 63-70, 1996.
34. M Windle, PT Davies. Depression and heavy alcohol use among adolescents: concurrent and prospective relations. Dev Psychopathol 11: 823-844, 1999.
35. JE Alpert, M Fava, LA Uebelacker, AA Nierenberg, JA Pava, JJ Worthington III, JF Rosenbaum. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry 15: 202-211, 1999.
36. CA King, N Ghaziuddin, L McGovern, E Brand, E Hill, M Naylor. Predictors of comorbid alcohol and substance abuse in depressed adolescents. J Am Acad Child Adolesc Psychiatry 35: 743-751, 1996.
37. HM Pettinati, JD Pierce Jr, AL Wolf, RM Rukstalis, CP O’Brien. Gender differences in comorbidly depressed alcohol-dependent outpatients. Alcohol Clin Exp Res 21: 1742-1746, 1997.
38. BS Moscato, M Russell, M Zielezny, E Bromet, G Egri, P Mudar, JR Marshall. Gender differences in the relation between depressive symptoms and alcohol problems: a longitudinal perspective. Am J Epidemiol 146: 966-974, 1997.
39. JM Bjork, DM Dougherty, FG Moeller. Symptomatology of depression and anxiety in female “social drinkers.”. Am J Drug Alcohol Abuse 25: 173-182, 1999.
40. CA Prescott, SH Agger, KS Kendler. Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. Arch Gen Psychiatry 57: 803-811, 2000.
41. J Solomon. Alcoholism and psychiatric disorders. In Alcoholism: Biomedical and Genetic Aspects. HW Goedde, PD Agarwal, eds. New York: Pergamon Press, pp 216-227, 1989.
42. MA Schuckit, MG Monteiro. Alcoholism, anxiety and depression. Br J Addiction 83: 1371-1380, 1988.
43. MA Schuckit. Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. 4th ed. New York: Plenum, 1995.
44. SA Brown, MA Schuckit. Changes in depression among abstinent alcoholics. J Stud Alcohol 49: 412-417, 1988.
45. MA Schuckit. Alcohol and depression: a clinical perspective. Acta Psychiatrica Scandinavica 377: 28-32, 1994.
46. MH Keeler, CI Taylor, WC Miller. Are all recently detoxified alcoholics depressed? Am J Psychiatry 136: 4B586-588, 1979.
47. B Liskow, D Mayfield, J Thiele. Alcohol and affective disorder: assessment and treatment. J Clin Psychiatry 43: 144-147, 1982.
48. HM Pettinati, AA Sugarman, HS Maurer. Four year MMPI changes in abstinent and drinking alcoholics. Alcoholism: Clin Exp Res 6: 487-494, 1982.
49. KM Davidson. Diagnosis of depression alcohol dependence: changes in prevalence with drinking status. Br J Psychiatry 166: 199-204, 1995.
50. SA Brown, RK Inaba, JC Gillin, MA Schuckit, MA Stewart, MR Irwin. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry 152: 45-52, 1995.
51. H Roggla, A Uhl. Depression and relapses in treated chronic alcoholics. Int J Addict 30: 337-349, 1995.
52. SL Satel, TR Kosten, MA Schuckit, MW Fischman. Should protracted withdrawal from drugs be included in DSM-IV?. Am J Psychiatry 150: 695-704, 1993.
53. HE Ross, FB Glaser, T Germanson. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 45: 1023-1031, 1988.
54. HP Weingold, JM Lachin, HA Bell, et al. Depression as a symptom of alcoholism: search for a phenomenon. J Abnorm Psychol 73: 195-197, 1968.
55. AT McLellan, KA Druley. Random relation between drugs of abuse and psychiatric diagnoses. J Psychiatr Res 13: 179-184, 1977.
56. LR Herz, L Volicer N D’Angelo, D Gadish. Additional psychiatric illness by diagnostic interview scechule in male alcoholics. Comp Psychiatry 30: 72-79, 1990.
57. CA Dackis, J Bailey, ALL Potash, RF Stuckey, IL Extein, MS Gold. Specificity of the DST and the TRH test for major depression in alcoholics. Am J Psychiatry 141: 680-683, 1984.
58. WH Nelson, P Sullivan, A Khan, RN Tamragouri. The effect of age on dexamethasone suppression test results in alcoholic patients. Am J Psychiatry 143: 237-239, 1986.
59. MA Schuckit. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 143: 140-147, 1986.
60. JE Helzer, TR Pryzbeck. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 49: 219-224, 1988.
61. K O’Sullivan, P Williams, M Daly, et al. A comparison of alcoholics with and without co-existing affective disorder. Br J Psychiatry 143: 133-138, 1983.
62. MA Schuckit. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 42: 1043-1049, 1985.
63. M Schuckit. Alcoholic patients with secondary depression. Am J Psychiatry 140: 711-714, 1983.
64. MM Weissman, M Pottenger, K Kleber, et al. Symptom patterns in primary and secondary depression. Arch Gen Psychiatry 34: 854-862, 1977.
65. MN Hesselbrock, RE Meyer, JJ Keener. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 42: 1050-1055, 1985.
66. BJ Powell, MR Read, EC Penick, NS Miller, SF Bingham. Primary and secondary depression in alcoholic men: an important distinction?. J Clin Psychiatry 48: 98-101, 1987.
67. EB Raimo, MA Schuckit. Alcohol dependence and mood disorders. Addict Behav 23: 933-946, 1998.
68. MA Schuckit, JE Tipp, M Bergman, W Reich. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 154: 948-957, 1997.
69. SF Greenfield, RD Weiss, LR Muenz, LM Vagge, JF Kelly, LR Bello, J Michael. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 55: 259-265, 1998.
70. DC Hodgins, N el-Guebaly, S Armstrong, M Dufour. Implications of depression on outcome from alcohol dependence: a 3-year prospective follow-up. Alcohol Clin Exp Res 23: 151-157, 1999.
71. KM Davidson, IM Blackburn. Comorbid depression and drinking outcome in those with alcohol dependence. Alcohol Alcohol 33: 482-487, 1998.
72. F Fadda, ZL Rossetti. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56: 385-431, 1998.
73. JC Ballenger, FK Goodwin, LF Major, et al. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36: 224-227, 1979.
74. DA Gorelick. Serotonin uptake blockers and the treatment of alcoholism. In: Recent Developments in Alcoholism. Vol 7. M Galanter, ed. New York: Plenum, pp 267-281, 1989.
75. A Roy, M Virkkunen, M Linnoila. Serotonin in suicide, violence, and alcoholism. In: Serotonin in Major Psychiatric Disorders. EF Coccaro, DL Murphy, eds. Washington, DC: American Psychiatric Press, 1990.
76. L Branchey, M Branchey, S Shaw, CS Lieber. Relationship between changes in plasma amino acids and depression in alcoholic patients. Am J Psychiatry 141: 1212-1215, 1984.
77. AA Badawy. Tryptophan metabolism in alcoholism. Adv Exp Med Biol 467: 265-274, 1999.
78. AC Swann, BA Johnson, CR Cloninger, YR Chen. Relationships of plasma tryptophan availability to course of illness and clinical features of alcoholism: a preliminary study. Psychopharmacology 143: 380-384, 1999.
79. A Heinz, H Weingartner, D George, D Hommer, OM Wolkowitz, M Linnoila. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89: 97-106, 1999.
80. LE Hollister. Drug-induced psychiatric disorders and their management. Med Toxicol 1: 428-448, 1986.
81. DC Steffens, I Skoog, MC Norton, AD Hgart, JT Tschanz, BL Plassman, BW Wyse, KA Welsh-Bohmer, JC Breitner. Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry 57: 601-607, 2000.
82. HD Abraham, M Fava. Order of onset of substance abuse and depression in a sample of depressed outpatients. Compr Psychiatry 40: 44-50, 1999.
83. MA Chutuape, RK Brooner, M Stitzer. Sedative use disorders in opiate-dependent patients: association with psychiatric and other substance use disorders. J Nerv Ment Dis 185: 289-297, 1997.
84. RB Lydiard, MT Laraia, JC Ballenger, EF Howell. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 144: 664-665, 1987.
85. N Lin, SA Eisen, JFD Scherrer, J Goldberg, WR True, MJ Lyons, MT Tsuang. The influence of familial and non-familial factors on the association between major depression and substance abuse/dependence in 1874 monozygotic male twin pairs. Drug Alcohol Depend 43: 49-55, 1996.
86. C Fahlke, U Berggren, C Lundborg, J Balldin. Psychopathology in alcohol withdrawal: relationship to alpha2-adrenoceptor function. Alcohol Alcohol 34: 750-759, 1999.
87. A Heinz, P Dufeu, S Kuhn, M Dettling, K Graf, I Kurten, H Rommelspacher, LG Schmidt. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 53: 1123-1128, 1996.
88. JR Hubbard, SE Franco, ES Onaivi. Marijuana: medical implications. Am Family Physician 60: 2583-2588, 1999.
89. JA Halikas, Goodwin DW, Guze SB. Marijuana use and psychiatric illness. Arch Gen Psychiatry 27: 162-165, 1972.
90. RA Weller, JA Halikas. Marijuana use and psychiatric illness: a follow-up study. Am J Psychiatry 142: 848-850, 1985.
91. J Shedler, J Block. Adolescent drug use and psychological health: a longitudinal inquiry. Am Psychol 45: 612-630, 1990.
92. BW Lex, ML Griffin, NK Mello, Mendleson JH. Alcohol, marijuana, and mood states in young women. Int J Addict 24: 405-424, 1989.
93. SM Mirin, LM Shapiro RE Meyer, RC Pillard, S Fisher. Casual versus heavy use of marijuana: a redefinition of the marijuana problem. Am J Psychiatry 127: 1134-1140, 1971.
94. S Andreasson, P Allebeck. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scand J Soc Med 18: 8-15, 1990.
95. S Schnoll, AN Daghestani. Treatment of marijuana abuse. Psychiatr Annals 16: 249-254, 1986.
96. L Grinspoon, JB Bakalar. Marijuana In: Substance Abuse: A Comprehensive Textbook. 3rd ed. J Lowinson, P Ruiz, RB Millman, JG Langrod, eds. Baltimore: Williams & Wilkins, 1997.
97. LE Hollister. Health aspects of cannabis. Pharmacol Rev 38: 1-20, 1986.
98. RH Schwartz. Marijuana: an overview. Pediatr Clin North Am 34: 305-317, 1987.
99. MC Braude, S Szara. Pharmacology of marihuana. New York: Raven Press, 1976.
100. JH Mendleson, NK Mello, BW Lex, S Bavli. Marijuana withdrawal syndrome in a woman. Am J Psychiatry 141: 1289-1290, 1984.
101. LA Matsuda, LJ Lolait, MJ Brownstein, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
102. AC Howlett, M Bidaut-Russell, WA Devane, et al. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci 13: 420-423, 1990.
103. R Lu, JR Hubbard, BR Martin, MT Kalami. Roles of sulfhydryl and disulfide groups in the binding of CP-55, 940 to rat brain cannabinoid receptor. Mol Cel Biochem 121: 119-126, 1993.
104. ES Onaivi, A Chakraborti, G Chaudhuri. Cannabinoid receptor genes. Prog Neurobiol 48: 275-305, 1996.
105. G Nahas. Biomedical aspects of cannabis usage. Bull Narc 29: 13-27, 1977.
106. BGB Sethi, JK Trivedi, P Kumar, et al. Antianxiety effect of cannabis: involvement of central benzodiazepine receptors. Biol Psychiatry 21: 3-10, 1986.
107. FH Gawin, HD Kleber. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43: 107-113, 1986.
108. FH Gawin, EH Ellinwood. Cocaine and other stimulants. N Engl J Med 318: 1173-1182, 1988.
109. CA Dackis, TW Estroff, DR Sweeney, ALC Pottash, MS Gold. Specificity of the TRH test for major depression in patients with serious cocaine abuse. Am J Psychiatry 142: 1097-1099, 1985.
110. BJ Rounsaville, SF Anton, K Carroll, et al. Psychiatric diagnosis of treatment seeking cocaine abusers. Arch Gen Psychiatry 48: 43-51, 1991.
111. EV Nunes, FM Quitkin, DF Klein. Psychiatric diagnosis in cocaine abuse. Psychiatry Res 28: 105-114, 1989.
112. SM Mirin, RD Weiss. Affective illness in substance abusers. Psychiatr Clin North Am 9: 503-514, 1986.
113. SM Mirin, RD Weiss, J Michael, ML Griffin. Psychopathology in substance abusers and their families. Resident & Staff Physician 34: 61-65, 1988.
114. SM Mirin, RD Weiss, J Michael. Psychopathology in substance abusers: diagnosis and treatment. Am J Drug Alcohol Abuse 14: 139-157, 1988.
115. RD Weiss, SM Mirin, ML Griffin, JL Michael. Psychopathology in cocaine abusers. J Nerv Ment Dis 176: 719-725, 1988.
116. PH Kleinman, AB Miller, RM Millman, GE Woody, T Todd, J Kemp, DS Lipton. Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis 178: 442-447, 1990.
117. R Watson, E Hartmann, JJ Schildkraut. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry 129: 39-45, 1972.
118. TR Kosten, A Markou, GF Koob. Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 186: 737-45, 1998.
119. TA Kosten, TR Kosten, FH Gawin, et al. An open trial of sertraline for cocaine abuse. Am J Addictions 1: 349-353, 1992.
120. CA Dackis, MS Gold. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav 9: 469-477, 1985.
121. WC Hall, RL Talbert, L Ereshefsky. Cocaine abuse and its treatment. Pharmacotherapy 10: 47-65, 1990.
122. FH Gawin. New uses of antidepressants in cocaine abuse. Psychosomatics 27(suppl): 9, 1986.
123. NL Benowitz. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319: 1318-1330, 1988.
124. HJ Waal-Manning, FA de Hamel. Smoking habit and psychometric scores: a community study. NZ Med J 88: 188-191, 1978.
125. N Breslau, MM Kilbey, P Andreski. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 48: 1069-1074, 1991.
126. M Zimmerman, WH Coryell, DW Black. Cigarette smoking and psychiatric illness In: CME Syllabus and Scientific Proceedings in Summary Form, 144th Annual Meeting of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1991.
127. MG Goldstein, R Niaura, DB Abrambs. Medical and behavioral treatment of nicotine dependence. In: Advances in Medical-Psychiatric Practice. A Stoudemire, BS Fogel, eds. Washington, DC: American Psychiatric Press, 1990.
128. JR Hughes, DK Hatsukami, JE Mitchell, BA Dahlgren. Prevalence of smoking in psychiatric outpatients. Am J Psychiatry 143: 993-997, 1986.
129. AH Glassman, LS Covey, F Stetner. Smoking cessation, depression, and antidepressants. Abstract presented at the 142nd Annual Meeting of the American Psychiatric Association, May 1989.
130. SM Hall, R Munoz, V Reus. Smoking cessation, depression, and dysphoria. In: Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph Series. LS Harris, ed. Washington, DC: US Government Printing Office, 1992.
131. AH Glassman, JE Helzer, LS Covey, LB Cottler, F Stetner, JE Tipp, J Johnson. Smoking, smoking cessation, and major depression. JAMA 264: 1546-1549, 1990.
132. DB Kandel, M Davies. Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry 42: 255-262, 1986.
133. JR Hughes. Clonidine, depression and smoking cessation. JAMA 254: 2901-2902, 1988.
134. LS Covey, AH Glassman, F Stetner. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 31: 350-354, 1990.
135. AH Glassman, F Stetner, PS Walsh Raizman, JL Fleiss, TB Cooper, LS Covey. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 259: 2863-2866, 1988.
136. N Breslau, MM Kilbey, P Andreski. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 149: 464-469, 1992.
137. RF Anda, DF Williamson, LG Escobedo, EE Mast, GA Giovino, PL Remington. Depression and the dynamics of smoking: a national perspective. JAMA 264: 1541-1545, 1990.
138. S Shiffman. Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 50: 71-86, 1982.
139. T Frederick, RR Frerichs, VA Clark. Personal health habits and symptoms of depression at the community level. Prev Med 17: 173-182, 1988.
140. J Chetwynd. Some characteristics of women smokers. NZ Med J 99: 14-17, 1986.
141. AH Glassman. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 150: 546-553, 1993.
142. KS Kendler, MC Neale, CJ MacLean, AC Heath, LJ Eaves, RC Kessler. Smoking and major depression: a causal analysis. Arch Gen Psychiatry 50: 36-43, 1993.
143. JR Hughes, ST Higgins, DK Hatsukami. Effects of abstinence from tobacco: a critical review. In Research Advances in Alcohol and Drug Problems. Vol 10. LT Kozlowski, H Annis, HD Cappell, et al, eds. New York: Plenum, pp 317-398, 1990.
144. J Flanagan, I Maany. Smoking and depression [letter]. Am J Psychiatry 139: 540-541, 1982.
145. AH Glassman, L Covey, F Stetner. Smoking cessation and major depression. In: Proceedings of the 28th Annual Meeting of the American College of Neuropsychopharmacology. Nashville, TN: ACNP, 1989.
146. KO Fagerstrom. Towards better diagnoses and more individual treatment of tobacco dependence. Br J Addict 86: 543-547, 1991.
147. LS Covey, AH Glassman, F Stetner. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 31: 350-354, 1990.
148. SM Hall, R Munoz, V Reus. Smoking cessation, depression and dysphoria. In: Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph Series. LS Harris, ed. Washington, DC: US Government Printing Office, 1992.
149. RJ West, P Hajek, M Belcher. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 19: 981-985, 1989.
150. JR Hughes. Tobacco withdrawal in self-quitters. J Consult Clin Psychol 60: 689-697, 1992.
151. PA Newhouse, JR Hughes. The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addiction 86: 521-526, 1991.
152. JA Bodkin, GL Zornberg, SE Lukas, JO Cole. Buprenophine treatment of refractory depression. J Clin Psychopharmacol 15: 49-57, 1995.
153. AL Stoll, S Rueter. Treatment augmentation with opiates in severe and refractory major depression. Am J Psychiatry 156: 2017, 1999.
154. SM Mirin, RE Meyer, HB McNamee. Psychpathology and mood during heroin use: acute vs. chronic effects. Arch Gen Psychiatry 33: 1503-1508, 1976.
155. WR Martin, DR Jasinski. Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence. J Psychiatr Res 7: 9-17, 1967.
156. WR Martin, DR Jasinski, CA Haertzen et al. Methadone-a reevaluation. Arch Gen Psychiatry 28: 286-295, 1973.
157. BJ Rounsaville, MM Weissman, H Kleber, C Wilber. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 39: 151-156, 1982.
158. JL Croughan, JP Miller, D Wagelin, BY Whitman. Psychiatric illness in male and female narcotic addicts. J Clin Psychiatry 43: 225-228, 1982.
159. A Dackis, MS Gold. Opiate addiction and depression-cause or effect?. Drug Alcohol Depend 11: 105-109, 1983.
160. MM Weissman, F Slobetz, B Prusoff, M Mezritz, P Howard. Clinical depression among narcotic addicts maintained on methadone in the community. Am J Psychiatry 133: 1434-1438, 1976.
161. RK Brooner, VL King, M Kidorf, CW Schmidt, GE Bigelow. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 54: 71-80, 1997.
162. DD Brewer, RF Catalano, K Haggerty, RR Gainey, CB Fleming. A meta-analysis of predictors of continued drug use druing and after treatment for opiate addiction. Addiction 93: 73-92, 1998.
163. JF Maddux, DP Desmond, R Costello. Depression in opioid users varies with substance use status. Am J Drug Alcohol Abuse 13: 375-385, 1987.
164. A Rosenblum, B Fallon, S Magura, L Handelsman, J Foote, D Bernstein. The autonomy of mood disorders among cocaine-using methadone patients. Am J Drug Alcohol Abuse 25: 67-80, 1999.
165. BA Sproule, UE Busto, G. Somer, MK Romach, EM Sellers. Characteristics of dependent and nondependent regular users of codeine. J Clin Psychopharmacol 19: 367-372, 1999.
166. MK Romach, BA Sproule, EM Sellers, G Somer, UE Busto. Long-term codeine use is associated with depressive symptoms. J Clin Psychopharmacol 19: 373-376, 1999.
167. EC Strain, ML Stitzer, GE Bigelow. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis 179: 215-221, 1991.
168. BJ Rounsaville, MM Weissman, K Crits-Christoph, C Wilber, H Kleber. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch Gen Psychiatry 39: 151-156, 1982.
169. BJ Rounsaville, TR Kosten, MM Weissman, B Prusoff, D Pauls, SF Anton, K Merikangas. Psychiatric disorders in relative of probands with opiate addiction. Arch Gen Psychiatry 48: 33-42, 1991.
170. E Nestler. Molecular mechanisms of drug addiction. Neuroscience 12: 2439-2450, 1992.
171. JH Jaffe, WR Martin. Opioid analgesics and antagonists. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 8th ed. AG Gilman, TW Rall, AS Nies, P Taylor, eds. New York: Pergamon Press, pp. 485-521, 1990.
172. JM Musacchia. The psychotomimetic effects of opiates and the sigma receptor. Neuropsychopharmacology 3: 191-200, 1990.
173. HM Emrich. A possible role of opioid substances in depression. Adv Biochem Psychopharmacol 32: 77-84, 1982.
174. I Extein, AL Pottash, MS Gold. A possible opioid receptor dysfunction in some depressive disorders. Ann NY Acad Sci 398: 113-119, 1982.
175. L Handelsman, MJ Aronson, R Ness, KJ Cochrane, PD Kanof. The dysphoria of heroin addiction. Am J Drug Alcohol Abuse 18: 275-287, 1992.
176. J Westermeyer. The psychiatrist and solvent-inhalant abuse: recognition, assessment, and treatment. Am J Psychiatry 144: 903-907, 1987.
177. J Crites, MA Schuckit. Solvent misuse in adolescents at a community alcohol center. J Clin Psychiatry 40: 39-43, 1979.
178. SH Dinwiddie, CF Zorumski, EH Rubin. Psychiatric correlates of chronic solvent abuse. J Clin Psychiatry 48: 334-337, 1987.
179. S Williamson, M Gossop, B Powis, P Griffiths, J Fountain, J Strang. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 44: 87-94, 1997.
180. F Schifano, L Di Furia, G. Forza, N Minicuci, R Bricolo. MDMA (“ecstasy”) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52: 85-90, 1998.
181. PK McGuire, H Cope, TA Fahy. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (“Ecstasy”). Br J Psychiatry 165: 391-395, 1994.
182. SR White, T Obradovic, KM Imel, MJ Wheaton. The effects of methylenedioxymethamphetamine (MDMA, “Ecstasy”) on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49: 455-79, 1996.
183. CJ Schmidt, VL Taylor. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methyleledioxymethamphetamine. Biochem Pharmacol 36: 4095-4102, 1987.
184. SJ Peroutka, H Newman, H Harris. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1: 273-277, 1988.
185. HV Curran, RA Travill. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): week-end “high” followed by mid-week low. Addiction 92: 821-831, 1997.
186. AC Parrott, J Lasky. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139: 261-268, 1998.
187. SB Patten, JV Williams, EJ Love. Depressive symptoms attributable to medication exposure in a medical inpatient population. Can J Psychiatry 41: 651-654, 1996.
188. NS Miller, BM Belkin, MS Gold. Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment. Compr Psychiatry 32: 153-165, 1991.
189. SB Patten, EJ Love. Drug-induced depression. Psychother Psychosom 66: 63-73, 1997.
190. K Rickels, E Schweizer, WG Case, DJ Greenblatt. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47: 899-907, 1990.
191. M Lader. Anxiety or depression during withdrawal of hypnotic treatments. J Psychosom Res 38(suppl 1): 113-123, 1994.
192. DA Charney, AM Paraherakis, KJ Gill. The treatment of sedative-hypnotic dependence: evaluating clinical predictors of outcome. J Clin Psychiatry 61: 190-195, 2000.